The protein expression of CLDN-4 was positively correlated to Ki-67 labeling index among BrCa patients [37, 43], indicating that CLDN-4 might be contributed to proliferative pathways and cellular differentiation. This evidence concerns the gene MKI67 and invasive breast carcinoma.